Geron
FDA approves Geron’s Rytelo for treatment of MDS with transfusion-dependent anaemia
June 7, 2024Medical Communications FDA, Geron, Haematology, anaemia, mds
Geron Corporation has announced that the US Food and Drug Administration (FDA) has approved Rytelo (imetelstat) for the treatment of …
First stem cell trial halted due to costs
November 18, 2011Research and Development Geron, Stem cells
One of the world’s first stem cell trials has been put on hold due to ‘uncertain economic conditions’.Geron, the firm undertaking …
First patient treated in groundbreaking stem cell trial
November 16, 2010Research and Development GRNOPC1, Geron, PISCES, Pilot Investigation of Stem Cells in Stroke, ReN001, ReNeuron, Stem cells, ischaemic stroke, stroke
The first patient has been treated in a groundbreaking stem cell trial as part of a bid to develop a …
Stem cell trial re-starts
October 12, 2010Research and Development Geron, Stem cells, spinal injury
Geron Corporation has enrolled the first patient in its restarted clinical trial of human embryonic stem cells (hESC). The world’s …
Stem cell trial can re-start
August 2, 2010Research and Development Geron, Stem cells, spinal injury, stem cell
US regulators have given the green light for the first human trial of an embryonic stem cell therapy to resume. …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
